Permitting Product Liability Litigation for FDA-Approved Drugs and Devices Promotes Patient Safety

被引:6
作者
Kesselheim, A. S. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
关键词
D O I
10.1038/clpt.2009.213
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In 2008 and 2009, the Supreme Court reviewed the question of whether patients injured by dangerous prescription drugs or medical devices can bring tort lawsuits against pharmaceutical and device manufacturers. The Court ruled that claims against device manufacturers were preempted while claims against pharmaceutical manufacturers were not. The threat of product liability lawsuits promotes patient safety by encouraging manufacturers to take greater responsibility in providing clear warnings about known adverse effects of their products.
引用
收藏
页码:645 / 647
页数:3
相关论文
共 5 条
[1]   The role of litigation in defining drug risks [J].
Kesselheim, Aaron S. ;
Avorn, Jerry .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (03) :308-311
[2]   The Supreme Court, Preemption, and Malpractice Liability [J].
Kesselheim, Aaron S. ;
Studdert, David M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (06) :559-561
[3]  
Kessler DA, 2008, GEORGETOWN LAW J, V96, P461
[4]   Semper Fidelis - Consumer protection for patients with implanted medical devices [J].
Maisel, William H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (10) :985-987
[5]  
Mundy A, 2009, WALL STREET J 0114